NCT00596505View on ClinicalTrials.gov

Intravitreal Bevacizumab Pretreatment for Reducing Preretinal Hemorrhage in Diabetic Vitrectomy

CompletedOBSERVATIONAL
Enrollment

41

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2007

Conditions
Proliferative Diabetic Retinopathy
Trial Locations (1)

100

Department of Ophthalmology, National Taiwan University Hospital, Taipei

All Listed Sponsors
lead

National Taiwan University Hospital

OTHER

NCT00596505 - Intravitreal Bevacizumab Pretreatment for Reducing Preretinal Hemorrhage in Diabetic Vitrectomy | Biotech Hunter | Biotech Hunter